SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001140361-24-037673
Filing Date
2024-08-16
Accepted
2024-08-16 16:06:00
Documents
19
Effectiveness Date
2024-08-16

Document Format Files

Seq Description Document Type Size
1 S-3ASR ny20034062x1_s3asr.htm S-3ASR 368619
2 EXHIBIT 4.4 ny20034062x1_ex4-4.htm EX-4.4 297255
3 EXHIBIT 4.5 ny20034062x1_ex4-5.htm EX-4.5 277813
4 EXHIBIT 5.1 ny20034062x1_ex5-1.htm EX-5.1 32155
5 EXHIBIT 23.1 ny20034062x1_ex23-1.htm EX-23.1 3470
6 ny20034062x1_exfee.htm   iXBRL EX-FILING FEES 36773
7 logo_rocketpharma.jpg GRAPHIC 36798
8 ny20034062x1_ex5-1image01.jpg GRAPHIC 2269
  Complete submission text file 0001140361-24-037673.txt   1226636

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT ny20034062x1_exfee_htm.xml XML 16918
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-281606 | Film No.: 241216719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)